Franklin Genomic Advancements ETF (HELX) Dividend Yield, History & Forecast

Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund (ETF) listed on the Chicago Board Options Exchange. The most recent ex-dividend date was December 30, 2025, with payment scheduled for January 8, 2026. market capitalization is approximately $17M.

Frequently Asked Questions about Franklin Genomic Advancements ETF (HELX)

When does Franklin Genomic Advancements ETF pay distributions?
The most recent ex-dividend date was December 30, 2025. The next scheduled dividend payment date is January 8, 2026.
What does Franklin Genomic Advancements ETF invest in?
The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. The fund invests in companies that are relevant to its investment theme of genomic advancements that the investment manager believes are substantially focused on/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business.